F21AS00422: Rhinoceros and Tiger Conservation Fund-Asia
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Fish and Wildlife Service notices from 2021.
Fish and Wildlife Service offered grants of up to $500,000 (at least $50,000) to the applicants described in the notice. It expected to make $6.6 million in total. Applications closed on May 21, 2021.
From the official notice on Grants.gov, last changed April 30, 2021. Checked November 7, 2026.
- Award ceiling$500,000
- Award floor$50,000
- Total funding$6.6 million
- Cost sharingNot required
- Funding typeCooperative Agreement, Grant
Key dates
| Posted | March 24, 2021 |
|---|---|
| Deadline | May 21, 2021 |
| Archived by Grants.gov | March 18, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Applicants can be individuals; multi-national secretariats; foreign national and local government agencies; non- profit non-governmental organizations; for-profit organizations; public and private institutions of higher education, U.S. territorial governments.
Is this a realistic fit?
- Past Rhinoceros and Tiger Conservation Fund awards averaged $348,465; this notice allows up to $500,000 per award.
- Most of the program's money (77% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The U.S. Fish and Wildlife Service’s mission is to work with others to conserve, protect and enhance fish, wildlife and plants and their habitats for the continuing benefit of the American people. The International Affairs Program delivers on this mission through its financial assistance programs by supporting strategic projects that deliver measurable conservation results for priority species and their habitats around the world. The Rhinoceros and Tiger Conservation Act was passed in 1994 to provide financial resources for conservation of rhinoceroses and tiger populations. This Funding Opportunity aligns with the U.S. Fish and Wildlife Service’s (Service) mission. The Rhinoceros and Tiger Conservation Fund (RTCF) is soliciting proposals for the conservation of rhinoceros and/or tigers throughout their ranges. Proposal objectives should align with one or more of the desired results identified below under the relevant funding priority. The Rhinoceros and Tiger Conservation Fund supports projects that promote conservation through: Support of protected area/reserve management and law enforcement in important rhinoceros and tiger range; Enhanced protection of the most at-risk rhinoceros and tiger populations; Habitat conservation, restoration and management; Strengthening local capacity and enhancing community engagement to implement conservation programs that enhance conservation stewardship; Efforts to decrease human-rhinoceros and human-tiger conflicts; Applied research on rhinoceros and tiger populations and their habitats, including surveys and monitoring; Compliance with applicable treaties (such as the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES)) and laws that regulate the taking or trade of rhinoceroses and tigers or regulate the use and management of their habitat; Reducing demand for illegal rhinoceros and tiger parts, products and live animals in consumer countries; Combating trafficking of rhinoceros and tiger parts, products and live animals; Reintroduction of rhinoceros to former range; and, Trans-frontier tiger conservation; Proposed project work should occur within the rhinoceros or tiger range, or, if work is to be conducted outside of the range, the proposal should show clear relevance to rhinoceros or tiger conservation.
Who has won Rhinoceros and Tiger Conservation Fund grants before
From fiscal 2021 to 2025, Rhinoceros and Tiger Conservation Fund (15.619) awarded $23.0 million across 66 grant awards, an average of $348,465 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Save the Rhino International | 6 | $4.9 million | |
| Zoologische Gesellschaft Frankfurt Von 1858 E.V. | 3 | $2.0 million | |
| Wildlife Conservation Society | New York | 10 | $2.0 million |
| Aaranyak | 6 | $1.7 million | |
| The International Rhino Foundation | Texas | 3 | $1.6 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is F21AS00422 still open?
No. It closed on May 21, 2021.
Who can apply for Rhinoceros and Tiger Conservation Fund-Asia?
Fish and Wildlife Service accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rhinoceros and Tiger Conservation Fund-Asia?
Closed May 21, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $6.6 million in total.
Who has won Rhinoceros and Tiger Conservation Fund grants before?
The largest recipients over five fiscal years were Save the Rhino International, Zoologische Gesellschaft Frankfurt Von 1858 E.V., Wildlife Conservation Society. The program made 66 awards worth $23.0 million in that time.
Similar open grants
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- DARRP Restoration Implementation Grants (2026)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)